CD4(+) CD56(+) Lineage-Negative Malignancies Are Rare Tumors of Plasmacytoid Dendritic Cells
暂无分享,去创建一个
R. Larson | E. Burks | Carla S. Wilson | K. Reichard | J. Hozier | D. Viswanatha | M. K. Foucar | E. J. Burks | M. Foucar
[1] P. Jaen,et al. [Blastic NK-cell lymphoma]. , 2006, Actas dermo-sifiliograficas.
[2] B. Gunawan,et al. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells. , 2004, European journal of dermatology : EJD.
[3] C. Aul,et al. Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes , 2004, Annals of Hematology.
[4] M. Teitell,et al. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. , 2004, American journal of clinical pathology.
[5] V. Deneys,et al. Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts , 2004, European journal of immunology.
[6] M. Teitell,et al. A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm) , 2004, The British journal of dermatology.
[7] A. Órfão,et al. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. , 2004, Haematologica.
[8] R. Dummer,et al. Blastic natural killer‐cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? , 2003, The British journal of dermatology.
[9] I. Hand. Verhaltenstherapie – Schutz vor Mythologie und Magie in der Psychotherapie? , 2003, Verhaltenstherapie.
[10] M. Wasik,et al. Complete remission in advanced blastic NK‐cell lymphoma/leukemia in elderly patients using the hyper‐CVAD regimen , 2003, American journal of hematology.
[11] M. Béné,et al. Plasmacytoid dendritic cells: from the plasmacytoid T-cell to type 2 dendritic cells CD4+CD56+ malignancies. , 2003, Seminars in hematology.
[12] T. Petrella,et al. Skin manifestations in CD4+, CD56+ malignancies. , 2003, EJD. European journal of dermatology.
[13] S. Whittaker,et al. Clinical and Laboratory Investigations Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the U.K , 2003 .
[14] M. Béné,et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. , 2003, Haematologica.
[15] B. Simões,et al. Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity. , 2002, Leukemia research.
[16] T. Petrella,et al. `Agranular CD4+ CD56+ Hematodermic Neoplasm' (Blastic NK-Cell Lymphoma) Originates From a Population of CD56+ Precursor Cells Related to Plasmacytoid Monocytes , 2002, The American journal of surgical pathology.
[17] Y. Aizawa,et al. Cutaneous lymphoblastic lymphoma of putative plasmacytoid dendritic cell-precursor origin: two cases. , 2002, Leukemia research.
[18] M. Callanan,et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. , 2002, Blood.
[19] J. Manning,et al. CD56+ TdT+ blastic natural killer cell tumor of the skin , 2002, Cancer.
[20] B. Drénou,et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. , 2002, Blood.
[21] H. Mossafa,et al. Agranular CD4+/CD56+ Cutaneous Neoplasm , 2002, Leukemia & lymphoma.
[22] K. Grønbæk,et al. A case of lymphoblastoid natural killer (NK)‐cell lymphoma: association with the NK‐cell receptor complex CD94/NKG2 and TP53 intragenic deletion , 2002, The British journal of dermatology.
[23] C. Rakozy,et al. Blastic natural killer cell lymphoma/leukemia: a report of seven cases. , 2002, American journal of clinical pathology.
[24] Mary F Lipscomb,et al. Dendritic cells: immune regulators in health and disease. , 2002, Physiological reviews.
[25] P. M. Long,et al. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. , 2001, American journal of clinical pathology.
[26] A. Samri,et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. , 2001, Blood.
[27] R. Gressin,et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. , 2001, Blood.
[28] N. Kakazu,et al. Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma , 2001, Annals of Hematology.
[29] T. Mishina,et al. CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy. , 2001, Journal of the American Academy of Dermatology.
[30] Tetsuya Yamada,et al. Infant Leukemia Suggestive of Natural Killer Cell Precursor Origin Followed an Unusual Clinical Course , 2001, Acta Haematologica.
[31] Y. Yamashita,et al. Clinicopathological analyses of 5 Japanese patients with CD56+ primary cutaneous lymphomas. , 2000, International journal of hematology.
[32] L. Medeiros,et al. Natural killer-cell lymphoma involving the gynecologic tract. , 2000, Archives of pathology & laboratory medicine.
[33] Nürnberg Ag,et al. Tagungen und Kongresse · Meetings and Conferences , 2000, Visceral Medicine.
[34] A. Órfão,et al. CD123 hiDendritic Cell Lymphoma: An Unusual Case of Non-Hodgkin Lymphoma , 1999, Annals of Internal Medicine.
[35] T. Molina,et al. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC). , 1999, The American journal of surgical pathology.
[36] Y. Hasegawa,et al. High-dose chemotherapy with peripheral blood stem cell rescue in blastoid natural killer cell lymphoma. , 1999, Leukemia & lymphoma.
[37] M. Bagot,et al. Do primary cutaneous non-T non-B CD4+CD56+ lymphomas belong to the myelo-monocytic lineage? , 1998, The Journal of investigative dermatology.
[38] K. Ooya,et al. A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature. , 1998, American journal of clinical pathology.
[39] K. Kawai,et al. CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin. , 1998, The American Journal of dermatopathology.
[40] D. Louie,et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. , 1997, The American journal of surgical pathology.
[41] U. Jäger,et al. Multiplex PCR for rapid detection of T‐cell receptor‐gamma chain gene rearrangements in patients with lymphoproliferative diseases , 1996, British journal of haematology.
[42] R. Dummer,et al. A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma. , 1996, Archives of dermatology.
[43] W. C. Chan,et al. Acute agranular CD4‐positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents , 1995, Cancer.
[44] K. Imai,et al. High expression of CD56 (N‐CAM) in a patient with cutaneous CD4‐positive lymphoma , 1994, American journal of hematology.
[45] J. Sloane,et al. Evaluation of Sensitivity, Specificity, and Reproducibility of an Optimized Method for Detecting Clonal Rearrangements of Immunoglobulin and T‐Cell Receptor Genes in Formalin‐Fixed, Paraffin‐Embedded Sections , 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[46] A. Morley,et al. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. , 1991, Blood.
[47] V. Zagonel,et al. EXPRESSION OF NATURAL KILLER ANTIGENS IN A SUBSET OF “ON‐T. NON‐B LYMPHOMA/LEUKAEMIA WITH HISTIOCYTIC FEATURES” , 1990, British journal of haematology.
[48] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .